Related Experiment Video
Updated: Jun 4, 2026

COVID-19 Seroprevalence Test for IgG Antibody Levels Among Healthy Donors Across Different Pandemic Phases in Jeddah
Published on: June 24, 2025
Seroprevalence of hepatitis A virus antibody in Bijapur, Karnataka
Insights
This study investigated Hepatitis A virus IgG antibody seroprevalence in 142 children from Bijapur, Karnataka. Results indicate a low endemicity, with 44.4% testing seropositive for anti-HAV IgG.
Area of Science:
- Epidemiology
- Immunology
Background:
- Hepatitis A virus (HAV) infection is a significant public health concern, particularly in developing regions.
- Understanding the seroprevalence of anti-HAV IgG antibodies is crucial for assessing population immunity and disease burden.
Discussion:
- The study assessed anti-HAV IgG seroprevalence in children aged 6 months to 15 years in Bijapur, a tier III city in Karnataka.
- Sociodemographic factors were analyzed in relation to serostatus.
- A seroprevalence of 44.4% was observed, suggesting a low endemicity for Hepatitis A in the studied population.
Key Insights:
- Bijapur, Karnataka, exhibits low endemicity for Hepatitis A virus infection among children.
- The findings provide baseline data for public health interventions and vaccination strategies in similar socio-economic settings.
- Further research is warranted to explore specific risk factors and longitudinal trends.
Outlook:
- Continued surveillance of Hepatitis A virus infection is recommended in similar regions.
- Public health initiatives may focus on targeted vaccination campaigns based on seroprevalence data.
- Investigating the impact of improved sanitation and hygiene on HAV transmission is essential.
Abstract:
We studied the seroprevalence of anti-HAV IgG in children of Bijapur a tier III city/backward district in Karnataka and its relation with sociodemographic parameters. Out of 142 children, 6 months to 15 years who were included, 63 (44.4%) were sero positive, suggesting that Bijapur is a low endemic area.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Poliomyelitis
Yellow Fever
Toxoplasmosis
